Evaluation of the prescription of oral hypoglycemic agents in the adult population with type 2 diabetes mellitus

Abstract

Errors in the prescription of drug treatment for type 2 diabetes are detected at the primary level of care. the purpose of this study was to evaluate the quality of the prescription of oral hypoglycemic agents in patients attended in the family doctor's offices of the Hermanos Cruz University Polyclinic, Pinar del Río distrit, Cuba. A descriptive and cross-sectional study of the use of medications was carried out, classified within these as indication-prescription with elements of the therapeutic scheme and factors that condition prescription habits. The universe was made up of 1575 patients diagnosed with type 2 diabetes mellitus treated with oral hypoglycemic agents who belonged to the 20 family medical offices. The study sample was carried out by the non-probabilistic sampling method (for convenience) (n = 846). The information was obtained from the clinical history and control card of the patients to acquire these medications. The age of 40-49 years, the female sex and between 5-10 years of evolution of the disease predominated. The first line of treatment was not used in 43.6% of the cases; no case had laboratory studies for the use of Metformin. The prescription and dose was adequate, but not its rational use. The most frequent interactions were pharmacokinetic ones. The rational use of oral hypoglycemic agents was deficient, which makes it necessary to expand the dissemination of a treatment protocol to improve the use of these drugs at the primary level of care.

Polifarmacia en Pacientes Adultos Mayores y el Papel de Enfermería en el Primer Nivel de Atención en Salud de Santa Rosa. 2023

“…Gonzales J y colaboradores afirman que esto es porque las mujeres sobreviven más que los hombres, a pesar de estar expuestas con mayor pág. 8767 frecuencia a factores agresivos del medio en el que viven, debido a ello, tienden a presentar múltiples patologías en el transcurso de los años (González Casanova et al, 2019).…”

“…El grupo de los adultos mayores cada vez va en aumento, donde se estima que entre el 65% y 90 % tienden a presentar polifarmacia por sus diversas patologías convirtiéndose en un grupo de alto riesgo en cuanto al consumo excesivo de medicamentos (González Casanova et al, 2019). El origen de este riesgo radica en la coexistencia de múltiples enfermedades crónicas no transmisibles como las enfermedades cardiovasculares, metabólicas o síndromes geriátricos, propios del envejecimiento, pues se asocia a una mayor complejidad en el manejo terapéutico, deficiente adherencia al tratamiento, reacciones adversas medicamentosas (RAM) y complicaciones relacionadas con la morbimortalidad (Escobedo-Romero y Izquierdo-Fernández, 2023).…”